Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China

被引：0
|
作者：
Luo, Xingxian [1 ]
Xu, Yang [2 ,3 ]
Du, Xin [4 ]
Lv, Xufeng [5 ]
Chen, Si [5 ]
Yang, Yue [2 ,3 ]
Huang, Lin [1 ]
Zhang, Xiaohong [1 ]
机构：
[1] Peking Univ, Dept Pharm, Peoples Hosp, Beijing, Peoples R China
[2] Tsinghua Univ, Sch Pharmaceut Sci, Beijing, Peoples R China
[3] Natl Med Prod Adm, Key Lab Innovat Drug Res & Evaluat, Beijing, Peoples R China
[4] Tsinghua Univ, Vanke Sch Publ Hlth, Beijing, Peoples R China
[5] Natl Med Prod Adm, Ctr Drug Evaluat, Beijing, Peoples R China
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2024年 / 52卷
基金：
中国国家自然科学基金;
关键词：
SURVIVAL; ONCOLOGY;
D O I：
10.1016/j.lanwpc.2024.101238
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Participation of Black US Residents in Clinical Trials of 24 Cardiovascular Drugs Granted FDA Approval, 2006-2020
    Chen, Siliang
    Li, Jiarui
    JAMA NETWORK OPEN, 2021, 4 (03)
  • [22] Regulation of Generic Drugs in China: Progress and Effect of the Reform of the Review and Approval System
    Si Chen
    Xin Chen
    Mengsi Liu
    Zhenyu Xu
    Yue Yang
    Journal of Pharmaceutical Innovation, 2023, 18 : 340 - 348
  • [23] Regulation of Generic Drugs in China: Progress and Effect of the Reform of the Review and Approval System
    Chen, Si
    Chen, Xin
    Liu, Mengsi
    Xu, Zhenyu
    Yang, Yue
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2023, 18 (02) : 340 - 348
  • [24] Pancreatic Cancer: Recent Progress of Drugs in Clinical Trials
    Zhiyi Zhang
    Jie Song
    Cao Xie
    Jun Pan
    Weiyue Lu
    Min Liu
    The AAPS Journal, 23
  • [25] Pancreatic Cancer: Recent Progress of Drugs in Clinical Trials
    Zhang, Zhiyi
    Song, Jie
    Xie, Cao
    Pan, Jun
    Lu, Weiyue
    Liu, Min
    AAPS JOURNAL, 2021, 23 (02):
  • [26] Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development
    Krentz A.J.
    Rodriguez-Araujo G.
    Pharmaceutical Medicine, 2017, 31 (6) : 399 - 421
  • [27] Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval
    Wallach, Joshua D.
    Zhang, Audrey D.
    Skydel, Joshua J.
    Bartlett, Victoria L.
    Dhruva, Sanket S.
    Shah, Nilay D.
    Ross, Joseph S.
    JAMA NETWORK OPEN, 2021, 4 (11) : E2133667
  • [28] Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer
    Kesselheim, Aaron S.
    Myers, Jessica A.
    Avorn, Jerry
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2320 - 2326
  • [29] BTG CHALLENGES WITH CANCER DRUGS FROM CHINA
    不详
    EUROPEAN CHEMICAL NEWS, 1994, 62 (1629): : 24 - 24
  • [30] Challenges of globalization of cancer drug trials-recruitment in LMICs, approval in HICs
    Gyawali, Bishal
    Carson, Laura M.
    Berry, Scott
    Moraes, Fabio Y.
    LANCET REGIONAL HEALTH-AMERICAS, 2022, 7
12345